@article{a7c3df1d1ade4a60bbd2a216ea1125f5,
title = "OCT is an alternative to MRI for monitoring MS – YES",
author = "Sotirchos, {Elias S.} and Shiv Saidha",
note = "Funding Information: The author(s) declared receipt of the following financial support for the research, authorship, and/or publication of this article: This commentary was supported in part by a grant from the National Multiple Sclerosis Society (RG-1606-08768 to SS). Funding Information: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Elias Sotirchos receives funding through a Sylvia Lawry Physician Fellowship from the National Multiple Sclerosis Society. Shiv Saidha has received consulting fees from Medical Logix for the development of CME programs in neurology and served on scientific advisory boards for Biogen, Genzyme, Genentech Corporation, EMD Serono, and Novartis. He has received equity compensation for consulting from JuneBrain LLC, a retinal imaging device developer. He received research support from Genentech Corporation, Biogen, and the National MS Society and support from the Race to Erase MS foundation. He is a member of the working committee of the International Multiple Sclerosis Visual System (IMSVISUAL) Consortium and the program committee of the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS).",
year = "2018",
month = may,
day = "1",
doi = "10.1177/1352458517753722",
language = "English (US)",
volume = "24",
pages = "701--703",
journal = "Multiple Sclerosis Journal",
issn = "1352-4585",
publisher = "SAGE Publications Ltd",
number = "6",
}